Clinica Chimica Acta 1997: Vol 258 Index

9 Pages·1997·1.2 MB·English

ELSEVIER Clinica Chimica Acta 258 {
Author index
Volume 258 (1997)
Adachi, J., see Miwa, A 258, 125 De Gaetano, A., see Greco, A.V 258, 209
Amigo, | see Greco, A.V 258, 209 Demirel, M see Haklar, G 258, 20)
Arapinis, ¢ S. Kostaridou, C. Kattamis, Effec de Vries, I.H., see Janssens, P.M.W. 258, 179
tive detection of active HCV infection: HCV Doumas, B.T., T. Peters, Jr.. Serum and urine
RNA carrier state in a context free of hepati albumin: a progress report on their measure
tis symptoms 258, 91 ment and clinical significance 258, 3
Doumas, B.T., W.A. Watson, H.G. Biggs, Albu
Beijering, R.J.R., C.H. Gips, J.R. Huizenga, J min standards and the measurement of serum
Jager, A.J. Mackor, H. Salomons, E. Knol albumin with bromcresol green 258, 21
T.H. Lijnema, Whole blood and plasma water Jullaart, R.P.F., see Riemens, S.¢ 258, 105
in health and disease: longitudinal and trans
verse observations and correlations with skitiirk, A., see Haklar, G. 258, 20!
several different hematological and clinico K., J. Mitcheson, M.F. Laker, Effect of
chemical parameters 258, 59 0°C on lipid, lipoprotein and
Biggs, H.G., see Doumas, B.T apolipoprotein concentrations 258, 219
Bousser, | see Kutter, D 258
Gips, C.H., see Beijering, R.J.R. 258, 59
arbone, V., see Corso, G. 258, 193 Greco, A.V.. G Mingrone 4. De Gaetano, |
astagneto, M., see Greco, A.V. 258, 209 Amigo, L. Puglielli, M. Castagneto, F. Nervi
hetty, N.. N.H. Naran, A.R.P. Walker, H.¢ Uptake of dodecanedioic acid by isolated rat
Seftel, B.1. Joffe, F.J. Raal, Plasma fatty acid ver 258, 209
levels in South African interethnic male high
school pupils at different ultimate risks of Haklar, G.. M. Demirel, O. Peker, A. Eskitairk
coronary heart disease 258, 31 A. Isg6r, G. Sdyletir, A.S. Yalein, The func
hristensen, | see Hogdall, ¢ 258, 159 onal assessment of autotransplanted splenic
hristiansen, M., see Hogdall 258, 159 tussue by its capacity to remove oxidatively
lemmensen, I|., see Hogdall 258, 159 odified erythrocytes 258, 201
ooreman, M.P., see Mulder 258. 69 Heegdall, C.K.. M. Christiansen, L. Christensen
orso, G I Trivellone Motta \ A.K. Yazova, C. Koch, |. Clemmensen, B
Postighone, F.P. Mancini, V. Carbone, C. Na Nergaard-Pedersen, Monoclonal antibodies
poli, Effect of low density lipoprotein fatty human tetranectin, epitope character
acid composition on copper-induced peroxida zauion ind Ise in immunohistochem
tion: ‘H-nuclear magnetic resonance analy stry 258, 159
sis 258, 193 Higashi, K., see Shige, H. 258, 145
Couderc, R., see Lefévre, G 258 Hirohata, S., see Kajikawa, Y 258
Hoéitl, W., see Vogl, M. 258, 79
de Bruin, W.C.C., see Mulder, T.PJ. 258, 69 Hoogenberg, K., see Riemens, S.(
0009-898 1 97 $17.00 1997 Elsevier Science B.V
258 duthor index vol 258 (1997)
Huizenga, J.R., see Beijering, R.J.R. 258, 59 Mizuno, K., see Miwa, A. 258, 125
Huseby, N.-E., see Mortensen, B. 258, 47 Mortensen, B., N.-E. Huseby, Clearance of cir-
culating y-glutamyltransferase by the asialo
Ikewaki, K., see Shige, H. 258, 145 glycoprotein receptor. Enzyme forms with
Isg6r, A., see Haklar, G. 258, 201 different sialic acid content are eliminated at
Ishikawa, T., see Shige, H. 258, 145 different clearance rates and without apparent
desialylation 258, 47
Jager, J., see Beijering, R.J.R. 258, 59 Moss, D., M. Werner, Forty years of Clinica
Chimica Acta 258, |
Jansen, J.B.M.J., see Mulder, T.P.J. 258, 69
Janssens, A.R., see Mulder, T.P.J. 258, 69 Motta, A., see Corso, G. 258, 193
Janssens, P.M.W., S. Kuiper, I.H. de Vries, J.1 Mulder, T.P.J., A.R. Janssens, W.C.C. de Bruin,
W.H.M. Peters, M.P. Cooreman, J.B.M.J
Willems, I. Klasen, M. van Oosterwijk, J
Paardekooper, Coating in vitro of erythro- Jansen, Plasma glutathione S-transferase al-
cytes with Tamm Horsfall-Protein 258, 179 phal-I levels in patients with chronic liver
Joffe, B.1., see Chetty, N 258, 31 disorders 258, 69
Miller, M.M., see Vogl, M. 258, 79
Murakami, M., see Kajikawa, Y 258, 241
Kajikawa, Y., S. Kusachi, J. Kondo, |. Sano, K
Yamamoto, S. Hirohata, M. Murakami, T Murakami, T., see Kajikawa, Y 258, 241
Myara, I., see Lefévre, G. 258, 249
Murakami, T. Tsuji, Time-dependent alter
ations of serum levels of triple-helix domain
Nagai, T., see Okazaki, T. 258, 137
and 7S domain of type IV collagen in patients
Nakajima, K., see Shige, H. 258, 145
with acute myocardial infarction after success-
Nakamura, H., see Shige, H. 258, 145
ful reperfusion: limited relation to left ventric
ular ejection fraction 258, 241 Napoli, ( see Corso, G 258, 193
Naran, N.H., see Chetty, N. 258, 31
Kambris, Z., see Kutter, D. 258, 231
Nervi, F., see Greco, A.V 258, 209
Kattamis, C., see Arapinis, C. 258, 91
Nishiwaki, M., see Shige, H. 258, 145
Klasen, I., see Janssens, P.M.W 258, 179
Norgaard-Pedersen, B., see Hogdall, C.K
Knol, E., see Beijering, R.J.R 258, 59 159
Koch, C., see Hogdall, C.K. 258, 159
Kondo, J., see Kajikawa, Y. 258, 241
Okazaki, T., Y. Yanagisawa, T. Nagai, Analysis
Kostaridou, S., see Arapinis, C. 258, 91
of the affinity of each haptoglobin polymer
Kremer, A., see Kutter, D. 258, 23
for hemoglobin by two-dimensional affinity
Kuiper, S., see Janssens, P.M.W 258, 179
electrophoresis 258, 137
Kusachi, S., see Kajikawa, Y. 258, 241
Kutter, D., A. Kremer, F. Bousser, Z. Kambris, Paardekooper, J., see Janssens, P.M.W
4 simple and inexpensive screening test for
179
low protein levels in urine 258, 231
Peker, ©., see Haklar, G. 258, 201
Peters, T., Jr., see Doumas, B.T 258, 3
Laker, M.F., see Evans, K. 258, 219
Peters, W.H.M., see Mulder, T.P.J. 258,
Lefevre, G., I. Myara, J. Peynet, R. Couderc, G
Peynet, J., see Lefévre, G. 258, 249
Section Lipoprotéines, Effect of sucrose
Postiglione, 4.. see Corso, G 258, 193
80°C storage of plasma on between-site values
Puglielli, L., see Greco, A.V 258, 209
of low-density lipoprotein susceptibility to
copper-induced oxidation 258, 249 Raal, F.J., see Chetty, N. 258, 31
Lijnema, T.H., see Beijering, R.J.R. 258, 59 Riemens, S.C., A. van Tol, K. Hoogeenerb erg, T
van Gent, L.M. Scheek, W.J. Sluiter, R.P.F
Mackor, A.J., see Beijering, R.J.R. 258, 59 Dullaart, Higher high density lipoprotein
Mancini, F.P., see Corso, G. 258, 193 cholesterol associated with moderate alcohol
Mingrone, G., see Greco, A.V. 258, 209 consumption is not related to altered plasma
Mitcheson, J., see Evans, K. 258, 219 lecithin:cholesterol acyltransferase and lipid
Miwa, A., J. Adachi, K. Mizuno, Y. Tatsuno transfer protein activity levels 258, 105
Very long-chain fatty acid pattern in crush
syndrome patients in the Kobe Earth- Salomons, H., see Beijering, R.J.R
quake 258, 125 Sano, I|., see Kajikawa, Y 258, 24!
futhor index
Scheek, L.M., see Riemens, S.( 258. 105 van Gent, T., see Riemens, S.¢ 258. 105
Section Lipoprotéines, G., see Lefévre,G. 258 van Oosterwijk, M.. see Janssens, P.M.W
249
Seftel, H.C., see Chetty, N. 258, 31 van Tol, A., see Riemens, S.C. 258, 105
Shige, H., T. Ishikawa, K. Ikewaki, M. Nishi Vogl, M., M.M. Miller, W. Hditl, Clinical use
waki, K. Higashi, K. Nakajima, H. Naka fulness of percentage of free serum prostate
mura Remnant-like very-low-density specific antigen 258, 79
lipoprotein isolated from hypertnglyceridemic
patients by immunoaffinity chromatography
Walker, A.R.P.. see Chetty, N
suppressed 3-hydroxy-3-methylglutary! coen
Watson, W.A., see Doumas, B.T
zyme A activity of cultured human skin
Werner, M., see Moss, D. 258, |
fibroblasts 258, 145
Sluiter, W.J., see Riemens, S.¢ 258, 105 Willems, J.1 see Janssens, P.M.W
Séyletir, G., see Haklar, G 58, 20!
Yalcin, A.S., see Haklar, G. 258
Tatsuno, Y see Miwa, A Yamamoto, K.. see Kajikawa, Y
Trivellone I see Corso, G Yanagisawa, Y see Okazaki, T
Tsuji, T.. see Kajikawa, Y Yazova, A.K see Hogdall, C.K

>
ELSEVIER Clinica Chimica Acta
Subject index
Volume 258 (1997)
Alcohol, High density lipoproteins; Lecithin Cholestery! ester transfer protein. High density
cholesterol acyltransferase Cholestery! ipoproteins Alcohol Lecithin:cholesterol
ester transfer protein; Phospholipid transfer lItransferase, Phospholipid transfer proteir
protein 258, 105 258. 105
Alcoholic liver cirrhosis; Glteust athion_e S-trar_ hronic hepatitnoin s B; Glu, tathione S-transferase
ferase alpha; Enzyme immunoassay; Primary ——
ilpha; Enzyme immunoassay; Alcoholic liver
biliary cirrhosis; Primary sclerosing cholangi
cirrhosis; Primary biliary cirrhosis; Primary
tis; Chronic hepatitis B 258, 69
sclerosing cholangitis 258, 69
Antioxidants, Atherosclerosis; Lipid peroxida
tion; Diene production 258, 249 learance Glutamyltransferase, Asialoglyco
protem receptor, Sialic acid; Serum glyck
Asialoglycoprotein receptor Glutamyltrans proteins 258, 4
ferase; Sialic acid; Serum glycoproteins; Clear
ance 258, 47 oronary heart disease. Dictary fat intake
Plasma cholesterol; Plasma fatty acids 258
Asymptomatic, anti-HCV ~ HCV carrier, Non }
A. non-B hepatitis (NANB); Hepatitis C virus
(HCV) 258, 91 rush syndrome, Very long-chain fatty acids
Hexacosanoi acid: Hexacosenoic acid: Earth
Atherosclerosis, Antioxidants; Lipid peroxida quake: Erythrocyte 258, 125
tion; Diene production 258, 249
Dicarboxylic acid: Dodecanedioic acid: HPL‘
Bromcresol green; Serum albumin; Urinary a!
Isolated liver perfusion: Mathematical mod
bumin; Measurement; Bromcresol purple
els 258. 209
258, 3
Bromcresol purple; Serum albumin; Urinary al Diene production, Atherosclerosis; Antioxidants
bumin; Measurement; Bromcresol green 258 Lipid peroxidation 258, 249
Dietary fat intake: Coronary heart disease
Carbonyl! content, Heinz body; Splenic auto Plasma cholesterol: Plasma fatty acids 258
transplantation; Thiobarbituric acid reactive I
substances 258, 201
Disease. Whole blood water: Plasma water, He
Cholesterol; Triglycerides; Phospholipids; Sam matological and clinicochemical parameters
ple handling: Variation, sourceo f 258 19 Health 258, 59
0009-898 | 97 $17.06 1997 Elsevier Science B.V. A
262 Subject index vol 258 (1997)
Dodecanedioic acid; Dicarboxylic acid; HPL( Hepatitis C virus (HCV); Non-A, non-B hepati
Isolated liver perfusion; Mathematical mod tis (NANB); Asymptomatic, anti-HCV
els 258, 209 HCV carrier 258, 91
Earthquake; Crush syndrome; Very long-chain Hexacosanoic acid; Crush syndrome; Very long-
fatty acids; Hexacosanoic acid; Hexacosenoic chain fatty acids; Hexacosenoic acid; Earth
acid; Erythrocyte 258, 125 quake; Erythrocyte 258, 125
Enzyme immunoassay; Glutathione S-transferase Hexacosenoic acid; Crush syndrome; Very long-
alpha; Alcoholic liver cirrhosis; Primary bil- chain fatty acids; Hexacosanoic acid; Earth-
iary cirrhosis; Primary sclerosing cholangitis quake; Erythrocyte 258, 125
Chronic hepatitis B 258, 69
High density lipoproteins Alcohol
Epitope; Human tetranectin; Monoclonal anti- Lecithin:cholesterol acyltransferase, Chol-
body; Immunohistochemistry 258, 159 esteryl ester transfer protein; Phospholipid
transfer protein 258, 105
Erythrocyte; Crush syndrome; Very long-chain
fatty acids; Hexacosanoic acid; Hexacosenoic HMG CoA reductase activity; Immunoaffinity
acid; Earthquake 258, 125 chromatography; Remnant VLDL; Hyper
triglyceridemia 258, 145
Erythrocytes; Tamm Horsfall protein; In vitro
coating 258, 179 HPLC; Dodecanedioic acid; Dicarboxylic acid
Isolated liver perfusion; Mathematical
Extracellular matrix; Left ventriculography models 258, 209
Ventricular remodeling; Ischemic heart dis-
ease; Immunoassay; Ventricular function Human tetranectin; Monoclonal antibody; Epi
258, 241 tope; Immunohistochemistry 258, 159
y-Glutamyltransferase, Asialoglycoprotein recep- Hypertriglyceridemia; I[mmunoaffinity chromato
tor; Sialic acid; Serum glycoproteins; Clear graphy; Remnant VLDL; HMG CoA reduc-
ance 258, 47 tase activity 258, 145
Glutathione S-transferase alpha; Enzyme im Immunoaffinity chromatography: Remnant
munoassay; Alcoholic liver cirrhosis; Primary VLDL; Hypertriglyceridemia; HMG CoA
biliary cirrhosis; Primary sclerosing cholangi- reductase activity 258, 145
tis; Chronic hepatitis B 258, 69
Immunoassay; Left ventriculography; Ventricular
Haptoglobin, Hemoglobin Two-dimensional remodeling; Ischemic heart disease; Extra
affinity electrophoresis 258, 137 cellular matrix; Ventricular function 258
241
Health; Whole blood water; Plasma water
Hematological and clinicochemical parame- Immunohistochemistry : Human tetranectin
ters; Disease 258, 59 Monoclonal antibody; Epitope 258, 159
Heinz body; Carbonyl content; Splenic auto- In vitro coating; Erythrocytes: Tamm Horsfall
transplantation; Thiobarbituric acid reactive protein 258, 179
substances 258, 20]
Ischemic heart disease; Left ventriculography
Hematological and clinicochemical parameters: Ventricular remodeling; Extracellular matrix
Whole blood water; Plasma water; Health; Immunoassay; Ventricular function 258, 241
Disease 258, 59
Isolated liver perfusion; Dodecanedioic acid
Hemoglobin; Haptoglobin; Two-dimensional Dicarboxylic acid; HPL( Mathematical
affinity electrophoresis 258, 137 models 258, 209
Subject inde 258 (1997)
LDL; NMR; Oleic acid; Peroxidation; Oxygen Plasma cholesterol; Coronary heart disease
radicals 258, 193 Dietary fat intake; Plasma fatty acids 258
31
Lecithin:cholesterol acyltransferase, High density
lipoproteins; Alcohol; Cholesteryl ester trans Plasma fatty acids; Coronary heart disease
fer protein; Phospholipid transfer protein Dietary fat intake: Plasma cholesterol 258
258, 105 1;
Left ventriculography; Ventricular remodeling
Plasma water, Whole blood water: Hematologi
Ischemic heart disease, Extracellular matrix
cal and clinicochemical parameters; Health
Immunoassay: Ventricular function 258, 24]
Disease 258, 59
Lipid peroxidation Atherosclerosis Anti
oxidants; Diene production 258, 249 Primary biliary cirrhosis, Glutathione S-trans
ferase alpha; Enzyme immunoassay; Alcoholic
Mathematical models; Dodecanedioic acid liver cirrhosis; Primary sclerosing cholangitis
Dicarbox ylic acid HPL( Isolated liver Chronic hepatitis B 258, 69
perfusion 258, 209
Primary sclerosing cholangitis, Glutathione S
Measurement, Serum albumin: Urinary albumin transferase alpha; Enzyme immunoassay
Bromcresol green; Bromcresol purple 258, 3 Alcoholic liver cirrhosis; Primary biliary
cirrhosis; Chronic hepatitis B 258, 69
Monoclonal antibody Human tetranectin
Epitope; Immunohistochemistry 258, 159 Prostate cancer screening, Total prostate specific
antigen; Percentage of free prostate specific
Nigrosin, Screening test intigen -? 79
+2 ;
Proteins, Screening test; Urine: Nigrosin 258
NMR: LDL: Oleic acid: Peroxidation: Oxygen .>
radicals 258, 193
Remnant VLDI Immunoaffinitty chromato
Non-A, non-B hepatitis (NANB), Hepatitis (
graphy: Hypertriglyceridemias HMG CoA
virus (HCV) Asymptomatic, anti-HCV
reductase activity 258, 145
HCV carrier 258, 91
Sample handling, Cholesterol Triglycerides
Oleic acid; LDL: NMR: Peroxidation: Oxygen
Phospholipids; Variation, sourceo f 258, 219
radicals 258. 193
Screening test: Proteins: Urine: Nigrosin 258
Oxygen radicals, LDL; NMR; Oleic acid: Per ) +1
oxidation 258, 193
Serum albumin, Urinary albumin; Measurement
Percentage of free prostate specific antigen; Tota!
Bromcresol green; Bromcresol purple 258, 3
prostate specific antigen -rostate cancer
screening 258, 79
Serum glycoproteins Glutamyltransferase
Asialoglycoprotein receptor, Sialic acid; Clear
Peroxidation. LDI NMR; Oleic acid; Oxygen
radicals 258, 193 ance 258, 47
Phospholipids; Cholesterol; Triglycerides; Sample Sialic acid Glutamyltransferase, Asialoglyco
handling; Variation, source of 258, 219 protein receptor, Serum glycoproteins; Clear
ince 258, 47
Phospholipid transfer protein: High density lipo
proteins, Alcohol; Lecithin:cholesterol acyl Splenic autotransplantation, Carbonyl! content
transferase Cholestery! ester transier Heinz body: Thiobarbituric acid reactive sub
protein 258, 105 stances 258, 20]
264 Subject index vol 258 (1997)
Tamm Horsfall protein; Erythrocytes; In vitro Variation, source of; Cholesterol; Triglycerides
coating 258, 179 Phospholipids; Sample handling 258, 219
Thiobarbituric acid reactive substances; Carbony! Ventricular function; Left ventriculography
content; Heinz body; Splenic autotransplanta- Ventricular remodeling Ischemic _ heart
tion 258, 201 disease; Extracellular matrix; Immuno-
assay 258, 24]
Total prostate specific antigen; Percentage of free
prostate specific antigen; Prostate cancer Ventricular remodeling; Left ventriculography
screening 258, 79 Ischemic heart disease; Extracellular matrix
Immunoassay; Ventricular function 258, 24]
Triglycerides; Cholesterol; Phospholipids; Sam
ple handling; Variation, source of 258, 219 Very long-chain fatty acids; Crush syndrome
Hexacosanoic acid; Hexacosenoic acid; Earth-
Two-dimensional affinity electrophoresis; Hap- quake; Erythrocyte 258, 125
toglobin; Hemoglobin 258, 137
Whole blood water; Plasma water; Hematological
Urinary albumin, Serum albumin; Measurement: and clinicochemical parameters; Health
Bromcresol green; Bromcresol purple 258, 3 Disease 258, 59
Urine; Screening test; Proteins; Nigrosin 258
>2 4